跳到正文
medRxiv · 临床预印本· Xu, H., Razaz, N., Remaeus, K., Lee, J., Fink, K., McKay, K. A. ·· 1 天前AI 评分54

瑞典全国队列研究:孕早期母亲BMI较高与子代多发性硬化风险升高相关

Maternal body mass index in early pregnancy and offspring risk of multiple sclerosis: A population-based cohort study

AI 导读

瑞典全国人群队列研究纳入1992至2007年出生的1,524,863名单胎儿童并随访至2025年,随访期间1539名子代(0.1%)确诊多发性硬化,中位确诊年龄24岁。

正文

Abstract

Objective To examine whether prospectively recorded maternal BMI in early pregnancy is associated with offspring multiple sclerosis (MS) risk, including childhood-onset and adult-onset MS. Design Nationwide population-based cohort study. Setting Swedish national health and demographic registers. Participants 1,524,863 singleton children born in Sweden from 1992 to 2007 and followed through 2025. Exposures Maternal BMI recorded at the first antenatal visit, categorised as underweight (<18.5), normal weight (18.5-24.9), overweight (25.0-29.9), and obesity (≥30.0), and also modelled continuously. Main outcome measures MS in offspring, identified as at least three ICD-10 G35 codes recorded on separate dates. Cox models estimated adjusted hazard ratios (HR) and 95% confidence intervals (CI) adjusting for confounders. Results During follow-up, 1539 offspring (0.1%) were diagnosed with MS at a median age of 24 years (interquartile range, 20-27 years). MS incidence rates by maternal BMI category were 0.37 per 10,000 person-years for both underweight, and normal weight, 0.42 for overweight, and 0.45 for obesity. Compared with normal weight women, maternal overweight and obesity were associated with higher hazards of offspring MS, with adjusted HRs of 1.20 (95% CI, 1.05 to 1.37) and 1.35 (95% CI, 1.11 to 1.64), respectively. Onset-specific analyses showed similar findings for adult-onset MS and less precise but directionally consistent estimates for paediatric-onset MS. Each 1-unit increase in maternal BMI was associated with a 3%, 4%, and 3% higher hazard of overall, paediatric-onset, and adult-onset offspring MS, respectively. Conclusions In this population-based cohort study, higher maternal BMI were associated with an increased rate of MS in offspring. The findings provide large-scale prospective evidence that maternal adiposity may be related to offspring MS risk and support further investigation of the prenatal metabolic environment in the early-life origins of MS.

Competing Interest Statement

Dr McKay receives research support from the Swedish Research Council, ALF Medicine, and Bjarne Ahlstroms Foundation. Dr Fink has received research support from the Swedish Research Council, CIMED, ALF Medicine, Merck, Amicus, Novartis and UCB. Dr Razaz is funded by the ALF Medicine, and Swedish Research Council. Jimin J Lee receives research support from Fonds de Recherche de Sante Quebec and MS Canada. Dr Xu receives research support from the Swedish Neurofonden Foundation. The other authors have no competing interests to state.

Author Declarations

I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.

Yes

The details of the IRB/oversight body that provided approval or exemption for the research described are given below:

The study was approved by the Swedish Ethical Review Authority. The requirement for informed consent was waived as only anonymized registry data were used.

I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.

Yes

I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).

Yes

I have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.

Yes

Data Availability

The data are not publicly available due to privacy and data protection regulations and cannot be shared by the authors.

Funder Information Declared

Swedish Research Council, https://ror.org/03zttf063

来源:medRxiv · 临床预印本 · medrxiv.org